Novel therapies for the treatment of metastatic melanoma
Chouake, J.; Friedman, A.
Journal of Drugs in Dermatology Jdd 11(2): 271-273
2012
ISSN/ISBN: 1545-9616 PMID: 22270215 Document Number: 13777
Document emailed within 1 workday
Related Documents
Tawbi, H.; Tawbi, H. 2015: Combination therapies for treating metastatic melanoma Clinical Advances in Hematology and Oncology: H&o 13(4): 211-214Claveau, J.; Ho, V.; Petrella, T. 2014: Metastatic melanoma: optimizing outcomes by managing dermatologic toxicities associated with novel therapies Skin Therapy Letter 19(2): 1-4
Saha, S.; Mohanty, K.C. 2003: Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung Indian Journal of Experimental Biology 41(11): 1253-1258
Moro-Sibilot, D.; Coudurier, M. 2009: Targeted therapies in second line treatment of metastatic non-small cell lung cancer La Revue du Praticien 59(7): 955-956
Shistik, G.; Prakash, A.V.; Fenske, N.A.; Glass, L.F. 2007: Treatment of locally metastatic melanoma: a novel approach Journal of Drugs in Dermatology: Jdd 6(8): 830-832
Papachristou, D.N.; Fortner, J.J. 1983: Surgical treatment of metastatic melanoma confined to the liver International Surgery 68(2): 145-148
Dutcher, J.P. 2011: High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard Oncology 25(5): 427-428
Wilkes, G.M. 2011: Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma Oncology 25(7 Suppl Nurse Ed): 46-47
Frydland, M.; Elming, H.; Ahlehoff, O. 2014: Malignant melanoma with metastatic melanoma to the heart Ugeskrift for Laeger 176(25)
Patel, F.; Wilken, R.; Burrall, B.; Martinez, S.; Wells, V.; King, B.; Maverakis, E. 2014: Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines Dermatology Online Journal 20(11)
Skowronek, J.; Roszak, A. 1997: A case of metastatic malignant melanoma of the vagina with a background of primary vaginal melanoma--clinical case Ginekologia Polska 68(8): 390-393
van Groningen, J.J.; Bloemers, H.P.; Swart, G.W. 1995: Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display Cancer Research 55(24): 6237-6243
Sherer, Y.; Shoenfeld, Y. 1997: Tumor metastases--new experimental anti-metastatic therapies Harefuah 133(12): 636-641
Gotoh, M. 2009: Treatment and rehabilitation programs for young alcoholics: acquiring the ability through group therapies and cognitive-behavioral therapies to communicate with others to lead a new life Nihon Arukoru Yakubutsu Igakkai Zasshi 44(5): 579-603
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Wagner, A.D.; Zaman, K.; Peters, S.; Montemurro, M.; Leyvraz, S. 2010: Anti-angiogenic therapies for metastatic colorectal, breast and lung cancer: benefits and risks Revue Medicale Suisse 6(250): 1070-1073
Qutub, W.; Lewis, K.; Gonzalez, R.; Quaife, R.; Russ, P.; McCarter, M. 2006: Lymphangiomatosis masquerading as metastatic melanoma American Surgeon 72(4): 367-370
Mc Clay, E.F.; Mastrangelo, M.J. 1988: Systemic chemotherapy for metastatic melanoma Seminars in Oncology 15(6): 569-577
Carboni, F.; Graziano, F.; Lonardo, M.T.; Lepiane, P.; Santoro, R.; Lorusso, R.; Mancini, P.; Santoro, E. 2004: Pancreaticoduodenectomy for pancreatic metastatic melanoma Journal of Experimental and Clinical Cancer Research: Cr 23(3): 539-543
Kruse, J.; Heath, R. 1990: Melanoma metastatic to the gastrointestinal tract American Family Physician 41(1): 165-168